Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Insun Park

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Biochemical Pharmacology|June 25, 2025
Synthetic homoisoflavane derivatives suppress the growth of colorectal cancer cells by disturbing microtubule dynamicsHa-Eun Shin, Sangkyu Park, Sangil Kwon, et al.
Journal of Clinical Anesthesia|December 20, 2024
Reduction of postoperative pain and opioid consumption by VVZ-149, first-in-class analgesic molecule: A confirmatory phase 3 trial of laparoscopic colectomyHo-Jin Lee, Ji-Yeon Sim, Inkyung Song, et al.
Journal of Computer-Aided Molecular Design|September 8, 2017
In silico probing and biological evaluation of SETDB1/ESET-targeted novel compounds that reduce tri-methylated histone H3K9 (H3K9me3) levelInsun Park, Yu Jin Hwang, TaeHun Kim, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Biochemical Pharmacology|June 25, 2025
Synthetic homoisoflavane derivatives suppress the growth of colorectal cancer cells by disturbing microtubule dynamicsHa-Eun Shin, Sangkyu Park, Sangil Kwon, et al.
Journal of Clinical Anesthesia|December 20, 2024
Reduction of postoperative pain and opioid consumption by VVZ-149, first-in-class analgesic molecule: A confirmatory phase 3 trial of laparoscopic colectomyHo-Jin Lee, Ji-Yeon Sim, Inkyung Song, et al.
Journal of Computer-Aided Molecular Design|September 8, 2017
In silico probing and biological evaluation of SETDB1/ESET-targeted novel compounds that reduce tri-methylated histone H3K9 (H3K9me3) levelInsun Park, Yu Jin Hwang, TaeHun Kim, et al.
Pageof 7